Abstract OBJECTIVE: To study the effects of diallyl disulfide (DADS) on apoptosis of human leukemia K562 cells and possible mechanisms. METHODS: The morphologic changes of leukemia K562 cells after DADS treatment were observed by Hoechst 33258 staining. Cell apoptosis rates after different concentrations and different durations of DADS treatment were determined by flow cytometry. Fas, FasL and caspase-8 mRNA expression was estimated by reverse transcription-polymerase chain reaction (RT-PCR) 48 hrs after DADS treatment. RESULTS: The characteristics of apoptosis in K562 cells induced by DADS were observed. After 24 hrs of DADS treatment, the apoptosis rate of K562 cells increased from (11.60±0.83)% at the concentration of 10 mg/L to (37.94±0.87)% at the concentration of 40 mg/L. The apoptosis rate of K562 cells increased after 40 mg/L DADS with the increasing time from (37.94±0.87)% (24 hrs) to (47.02±0.66)% (72 hrs). Expression of Fas and caspase-8 mRNA increased, while FasL mRNA expression decreased significantly 48 hrs after DADS treatment compared with the control group (P<0.05). CONCLUSIONS: DADS can induce apoptosis of human leukemia K562 cells in a time- and concentration-dependent manner, possibly through increasing Fas and caspase-8 expression and decreasing FasL expression.
XIAO Zheng-Xiang,YIN Xiao-Cheng,TAN Yan-Fang et al. Effects of diallyl disulfide on apoptosis of human leukemia K562 cells and expression of Fas, FasL and caspase-8[J]. 中国当代儿科杂志, 2011, 13(1): 53-56.
XIAO Zheng-Xiang,YIN Xiao-Cheng,TAN Yan-Fang et al. Effects of diallyl disulfide on apoptosis of human leukemia K562 cells and expression of Fas, FasL and caspase-8[J]. CJCP, 2011, 13(1): 53-56.
［1］Dausch JG, Nixon DW. Garlic: a review of its relationship to malignant disease［J］. Prev Med, 1990, 19(1): 346-361.
［2］Amagase H, Petesch BL, Matsuura H, Kasuga S, Itakura Y. Intake of garlic and its bioactive components［J］. J Nutr, 2001,131(3s): 955S-962S.
［3］Kwon KB, Yoo SJ, Ryu DG, Yang JY, Rho HW, Kim JS, et al. Induction of apoptosis by diallyl disulfide through activation of caspase-3 in human leukemia HL-60 cells［J］. Biochem Pharmacol, 2002, 63(l): 41-47.
［4］Shimonishi T, Isse K, Shibata F, Aburatani I,Tsuneyama K, Sabit H, et al. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance［J］. Hepatology, 2000, 32(4 Pt 1): 761-769.
［5］Liang Y, Nylander KD, Yan C, Schor NF.Role of caspase 3-dependent Bcl-2 cleavage in potentiation of apoptosis by Bcl-2［J］.Mol Pharmacol, 2002, 61(1): 142-149.
［6］Zheng TS, Schlosser SF, Dao T, Hingorani R, Crispe IN, Boyer JL, et al. Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo［J］. Proc Natl Acad Sci, U S A,1998, 95(23): 13618-13623.
［7］Lee TB, Min YD, Lim SC, Kim KJ, Jeon HJ, Choi SM, et al. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells［J］. J Gastroenterol Hepatol, 2002, 17(1): 32-38.
［8］Kim SS, Won SJ, Kim NJ, Yoo JK, Bae K, Lee KT. 3-Oxoolean-12-en-27-oic acid isolated from aceriphyllum rossii induces caspase-8-dependent apoptosis in human promyelocytic leukemia HL-60 cells［J］. Biol Pharm Bull, 2009, 32(1): 91-98.
［9］Villa-Morales M, Santos J, Pérez-Gomez E, Quintanilla M, Fern-ndez-Piqueras J. A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas［J］ .Cancer Res, 2007, 67(11): 5107-5116.
［10］Crew KD, Gammon MD, Terry MB, Zhang FF, Agrawal M, Eng SM, et al.Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk［J］.Carcinogenesis, 2007, 28(12): 2548-2551.
